Remedent, Inc.
Period Ending Mar 31, 2014 Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Total Revenue 2,593 2,937 9,687 12,582
Cost of Revenue 965 1,433 2,228 3,948
Gross Profit 1,628 1,504 7,459 8,634
Operating Expenses
Research and Development 77 60 310 429
Sales, General and Admin. 2,047 2,944 7,103 7,194
Non-Recurring Items - - - -
Other 240 314 549 780
Operating Income (737) (1,814) (502) 231
Income From Continuing Operations
Add'l Income/Expense Items 1,235 818 2,330 (591)
Earnings Before Interest and Tax 654 (796) 2,001 (359)
Interest Expense 130 186 387 260
Earnings Before Tax 525 (982) 1,614 (620)
Income Tax - - 315 220
Minority Interest - - 808 707
Equity Earnings Unconsolidated Subsidiary 157 200 173 -
Net Income Cont. Operations 681 (782) 664 (1,547)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 525 (982) 664 (1,547)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 525 (982) 490 (1,547)